Concepedia

Publication | Open Access

Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma

DOIFull Paper Access

129

Citations

14

References

2022

Year

Nizar M. Tannir, Neeraj Agarwal, Camillo Porta, Nicola Jane Lawrence, Robert J. Motzer, Bradley A. McGregor, Richard J. Lee, Rohit Jain, Nancy B. Davis, Leonard J. Appleman,
JAMA Oncology

Abstract

ClinicalTrials.gov Identifier: NCT03428217.

References

YearCitations

Page 1